<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39388387</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>40</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Risk of Clade II Mpox Associated with Intimate and Nonintimate Close Contact Among Men Who Have Sex with Men and Transgender Adults - United States, August 2022-July 2023.</ArticleTitle><Pagination><StartPage>896</StartPage><EndPage>902</EndPage><MedlinePgn>896-902</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7340a2</ELocationID><Abstract><AbstractText>A global outbreak of clade II mpox associated with sexual contact, disproportionately affecting gay, bisexual, and other men who have sex with men (MSM), has been ongoing since May 2022. Information on types of contact most associated with transmission is limited. This report used data from a multijurisdictional vaccine effectiveness case-control study of sexually active persons aged 18-49 years who identified as MSM or transgender, collected during August 2022-July 2023. Odds of mpox associated with selected types of intimate and nonintimate close contact with a person with mpox were estimated. Among 457 case-patients and 1,030 control patients who met minimum data requirements, 150 (32.8%) case-patients and 57 (5.5%) control patients reported close contact with a person with mpox and were included in this analysis. Adjusted odds of mpox were 5.4 times as high among those who reported having condomless receptive anal sex with a person with mpox, compared with participants who reported close contact with a person with mpox and no condomless receptive anal sex with that person (OR = 5.4; p = 0.031). Although the mpox vaccine is highly effective, vaccination coverage remains low; a multifaceted approach to prevention remains important and should include vaccination promotion, safer sex practices, and increasing awareness that mpox continues to circulate.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chard</LastName><ForeName>Anna N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Dalton</LastName><ForeName>Alexandra F</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Alpha Oumar</ForeName><Initials>AO</Initials></Author><Author ValidYN="Y"><LastName>Moulia</LastName><ForeName>Danielle L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Deputy</LastName><ForeName>Nicholas P</ForeName><Initials>NP</Initials></Author><Author ValidYN="Y"><LastName>Zecca</LastName><ForeName>Italo B</ForeName><Initials>IB</Initials></Author><Author ValidYN="Y"><LastName>Quilter</LastName><ForeName>Laura A S</ForeName><Initials>LAS</Initials></Author><Author ValidYN="Y"><LastName>Kachur</LastName><ForeName>Rachel E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>McCollum</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Rowlands</LastName><ForeName>Jemma V</ForeName><Initials>JV</Initials></Author><Author ValidYN="Y"><LastName>Britton</LastName><ForeName>Amber N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Shua J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Licherdell</LastName><ForeName>Erin</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Still</LastName><ForeName>William L</ForeName><Initials>WL</Initials></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Adeline L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Castilho</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Markus</LastName><ForeName>Tiffanie M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Morrow</LastName><ForeName>Allison S</ForeName><Initials>AS</Initials></Author><Author ValidYN="Y"><LastName>Danza</LastName><ForeName>Phoebe</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>AmberJean P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Sophia Ibrahim</ForeName><Initials>SI</Initials></Author><Author ValidYN="Y"><LastName>Wegner</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Robyn</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Betancourt</LastName><ForeName>Gabriela S</ForeName><Initials>GS</Initials></Author><Author ValidYN="Y"><LastName>Zipprich</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sutton</LastName><ForeName>Melissa</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pathela</LastName><ForeName>Preeti</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Hawkins</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wendel</LastName><ForeName>Karen A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Feldstein</LastName><ForeName>Leora R</ForeName><Initials>LR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018451" MajorTopicYN="Y">Homosexuality, Male</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063106" MajorTopicYN="Y">Transgender Persons</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Jessica L. Castilho reports support from Copan Diagnostics. Karen A. Wendel reports institutional support from Hologic Inc and an unpaid leadership role in the Denver Metro Sexually Transmitted Infections Coalition. Jennifer Zipprich reports spousal employment at Pfizer. No other potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39388387</ArticleId><ArticleId IdType="pmc">PMC11466375</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7340a2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thornhill JP, Antinori A, Orkin CM. Monkeypox virus infection in humans across 16 countries—April–June 2022. N Engl J Med 2022;387:e69. 10.1056/NEJMoa2207323</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2207323</ArticleId><ArticleId IdType="pubmed">36546638</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott D, Hughes CM, Alroy KA, et al.; CDC Multinational Monkeypox Response Team. Epidemiologic and clinical characteristics of monkeypox cases—United States, May 17–July 22, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1018–22. 10.15585/mmwr.mm7132e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7132e3</ArticleId><ArticleId IdType="pmc">PMC9400536</ArticleId><ArticleId IdType="pubmed">35951487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe JD, Charniga K, Byrd KM, et al. Possible exposures among mpox patients without reported male-to-male sexual contact—six U.S. jurisdictions, November 1–December 14, 2022. MMWR Morb Mortal Wkly Rep 2023;72:944–8. 10.15585/mmwr.mm7235a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7235a2</ArticleId><ArticleId IdType="pubmed">37651279</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton AF, Diallo AO, Chard AN, et al.; CDC Multijurisdictional Mpox Case Control Study Group. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study—United States, August 19, 2022–March 31, 2023. MMWR Morb Mortal Wkly Rep 2023;72:553–8. 10.15585/mmwr.mm7220a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7220a3</ArticleId><ArticleId IdType="pmc">PMC10205167</ArticleId><ArticleId IdType="pubmed">37200229</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Safer sex, social gatherings, and mpox. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. Accessed June 7, 2024. https://www.cdc.gov/mpox/prevention/safer-sex-social-gatherings-and-mpox.html</Citation></Reference><Reference><Citation>Tuttle A, Hughes CM, Dvorak M, et al. Notes from the field: clade II mpox surveillance update—United States, October 2023–April 2024. MMWR Morb Mortal Wkly Rep 2024;73:474–6. 10.15585/mmwr.mm7320a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7320a4</ArticleId><ArticleId IdType="pmc">PMC11115435</ArticleId><ArticleId IdType="pubmed">38781102</ArticleId></ArticleIdList></Reference><Reference><Citation>Deputy NP, Deckert J, Chard AN, et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med 2023;388:2434–43. 10.1056/NEJMoa2215201</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2215201</ArticleId><ArticleId IdType="pmc">PMC10962869</ArticleId><ArticleId IdType="pubmed">37199451</ArticleId></ArticleIdList></Reference><Reference><Citation>Guagliardo SAJ, Kracalik I, Carter RJ, et al. Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine—United States, May 2022–May 2024. MMWR Morb Mortal Wkly Rep 2024;73:460–6. 10.15585/mmwr.mm7320a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7320a3</ArticleId><ArticleId IdType="pmc">PMC11115437</ArticleId><ArticleId IdType="pubmed">38781111</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen LD, Osadebe L, Katomba J, et al. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg 2015;93:410–5. 10.4269/ajtmh.15-0168</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0168</ArticleId><ArticleId IdType="pmc">PMC4530773</ArticleId><ArticleId IdType="pubmed">26013374</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan AM, Cenciarelli O, Colombe S, et al. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill 2022;27:2200620. 10.2807/1560-7917.ES.2022.27.36.2200620</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.36.2200620</ArticleId><ArticleId IdType="pmc">PMC9461311</ArticleId><ArticleId IdType="pubmed">36082686</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>